Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S40-S52
Closed Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 680
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetes Care (2021) Vol. 44, Iss. 11, pp. 2589-2625
Open Access | Times Cited: 440
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetologia (2021) Vol. 64, Iss. 12, pp. 2609-2652
Open Access | Times Cited: 244
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
Michelle T. Long, Mazen Noureddin, Joseph K. Lim
Gastroenterology (2022) Vol. 163, Iss. 3, pp. 764-774.e1
Open Access | Times Cited: 187
Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
Jae‐Seung Yun, Seung‐Hyun Ko
Metabolism (2021) Vol. 123, pp. 154838-154838
Open Access | Times Cited: 181
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra, Eelco J.P. de Koning
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 178
Impact of non-invasive biomarkers on hepatology practice: Past, present and future
Quentin M. Anstee, Laurent Castéra, Rohit Loomba
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1362-1378
Open Access | Times Cited: 149
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
Chandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. 29-38
Open Access | Times Cited: 121
Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
Diana Barb, Enrico Repetto, Michael Edward Stokes, et al.
Obesity (2021) Vol. 29, Iss. 11, pp. 1950-1960
Open Access | Times Cited: 113
Non‐alcoholic fatty liver disease and type 2 diabetes: An update
Chi‐Ho Lee, David Tak Wai Lui, Karen SL Lam
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 6, pp. 930-940
Open Access | Times Cited: 67
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier, Clémence M. Canivet, Charlotte Costentin, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 5, pp. 1243-1251.e12
Closed Access | Times Cited: 61
Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes
Norbert Hermanns, Dominic Ehrmann, Amit Shapira, et al.
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1883-1894
Open Access | Times Cited: 50
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 14, pp. 2714-2724
Open Access | Times Cited: 39
Normal triglyceride concentration and the risk of diabetes mellitus type 2 in the general population of China
Rubing Guo, Lianhua Wei, Yongtong Cao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD
Amy K. Mottl, Radica Z. Alicic, Christos Argyropoulos, et al.
American Journal of Kidney Diseases (2022) Vol. 79, Iss. 4, pp. 457-479
Open Access | Times Cited: 33
Influenza vaccination and COVID-19 infection risk and disease severity: A systematic review and multilevel meta-analysis of prospective studies
Marco Del Riccio, Saverio Caini, Guglielmo Bonaccorsi, et al.
American Journal of Infection Control (2024) Vol. 52, Iss. 9, pp. 1091-1098
Open Access | Times Cited: 6
Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective
Hayato Tanabe, Hiroaki Masuzaki, Michio Shimabukuro
Diabetes Research and Clinical Practice (2021) Vol. 180, pp. 109067-109067
Open Access | Times Cited: 40
Diabetes and Oral Health: Summary of Current Scientific Evidence for Why Transdisciplinary Collaboration Is Needed
Wenche S. Borgnakke, Prakash Poudel
Frontiers in Dental Medicine (2021) Vol. 2
Open Access | Times Cited: 33
Effect of a Web-Based Management Guide on Risk Factors in Patients With Type 2 Diabetes and Diabetic Kidney Disease
Juliana C.N. Chan, Yotsapon Thewjitcharoen, Thy Khue Nguyen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e223862-e223862
Open Access | Times Cited: 25
Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial
Merel M. Ruissen, José D. Torres, Bas S. Uitbeijerse, et al.
Diabetologia (2023) Vol. 66, Iss. 12, pp. 2213-2225
Open Access | Times Cited: 16
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know
Kenneth Cusi, Jeff Budd, Eric L. Johnson, et al.
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 29-38
Open Access | Times Cited: 5
Democratizing type 1 diabetes specialty care in the primary care setting to reduce health disparities: project extension for community healthcare outcomes (ECHO) T1D
Ashby F. Walker, Nicolas Cuttriss, Michael J. Haller, et al.
BMJ Open Diabetes Research & Care (2021) Vol. 9, Iss. 1, pp. e002262-e002262
Open Access | Times Cited: 29
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Improving diagnosis and treatment of hypomagnesemia
María Salinas, Maite López‐Garrigós, Emilio Flores, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 62, Iss. 2, pp. 234-248
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top